CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 92.40
+1.30 (1.43%)
Aug 19, 2026, 10:50 AM CST
CH Biotech R&D Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,874 | 1,819 | 1,636 | 1,515 | 1,434 | 1,019 |
Revenue Growth | 11.26% | 11.21% | 7.98% | 5.63% | 40.81% | 45.05% |
Gross Profit Gross Profit Growth | 1,577 | 1,527 | 1,365 | 1,260 | 1,135 | 847.95 |
Operating Income Operating Income Growth | 681.83 | 623.13 | 542.3 | 565.86 | 511.06 | 359.27 |
Net Income Net Income Growth | 604.7 | 464 | 476.39 | 463.29 | 465.42 | 291.5 |
Earnings Per Share EPS Growth | 5.88 | 4.50 | 4.61 | 4.73 | 4.72 | 2.97 |
EPS Growth | 66.63% | -2.39% | -2.54% | 0.21% | 58.92% | 189.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 1,728 | 1,648 | 1,464 | 1,393 | 1,325 | 922.88 |
Other Countries Other Countries Growth | 145.96 | 170.98 | 171.58 | 122.12 | 109.43 | 95.63 |
Total Total Growth | 1,874 | 1,819 | 1,636 | 1,515 | 1,434 | 1,019 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 643.92 | 397.27 | 482.13 | 943 | 533.1 | 326.79 |
Total Debt Total Debt Growth | 868.36 | 664.33 | 747.33 | 845.16 | 894.89 | 1,122 |
Net Cash (Debt) Net Cash Growth | -224.45 | -267.05 | -265.19 | 97.84 | -361.79 | -795.48 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.18 | -2.59 | -2.57 | 1.00 | -3.67 | -8.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 897.01 | 589.02 | 538.44 | 659.15 | 698.97 | 264.36 |
Capital Expenditures CapEx Growth | -155.64 | -123.34 | -588.42 | -113.68 | -113.89 | -71.92 |
Free Cash Flow Free Cash Flow Growth | 741.37 | 465.68 | -49.98 | 545.47 | 585.08 | 192.43 |
Free Cash Flow Growth | 351.16% | - | - | -6.77% | 204.04% | 53.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.14% | 83.93% | 83.44% | 83.18% | 79.11% | 83.25% |
Operating Margin | 36.38% | 34.25% | 33.15% | 37.35% | 35.64% | 35.27% |
Pretax Margin | 39.29% | 31.27% | 36.25% | 38.22% | 39.45% | 35.31% |
Profit Margin | 32.27% | 25.51% | 29.12% | 30.58% | 32.45% | 28.62% |
FCF Margin | 39.56% | 25.60% | -3.06% | 36.01% | 40.80% | 18.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.800 | 4.800 | 4.100 | 4.090 | 3.880 | 1.304 |
Dividend Per Share Growth | 17.07% | 17.07% | 0.24% | 5.41% | 197.48% | 199.98% |
Dividend Yield | 5.25% | 5.59% | 5.59% | 5.83% | 6.27% | 3.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.50 | 19.94 | 17.44 | 17.86 | 15.73 | 17.67 |
Forward PE | - | 15.46 | 15.46 | 14.40 | - | - |
P/FCF Ratio | 12.39 | 19.87 | - | 15.17 | 12.51 | 26.76 |
PS Ratio | 4.90 | 5.09 | 5.08 | 5.46 | 5.10 | 5.06 |